[시장보고서]웨어러블 주사기 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

웨어러블 주사기 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Wearable Injectors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1550098

리서치사 : Persistence Market Research

발행일 : 2024년 09월

페이지 정보 : 영문 219 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 최근 세계의 웨어러블 주사기 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 홍보 요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 인사이트를 제공합니다.

주요 인사이트

웨어러블 주사기 시장 규모(2024년) : 770만 달러
시장 예측 금액(2033년) : 1,780만 달러
세계 시장 성장률(CAGR 2024-2033년) : 9.8%

웨어러블 주사기 시장-보고 범위 :

웨어러블 주사기는 장기간에 걸쳐 피하에 약물을 투여하도록 설계된 고급 의료기기입니다. 이 장치는 당뇨병과 류마티스 관절염과 같은 만성 질환 관리를 지원하며 편리함과 사용 편의성을 선호합니다. 웨어러블 주사기 시장은 패치 펌프 및 자동 약물 전달 시스템과 같은 기술 혁신을 통해 환자의 컴플라이언스 및 치료 효과를 향상시키고, 병원, 클리닉, 재택 관리 환경 등 다양한 건강 관리 환경을 지원합니다.

시장 성장 촉진요인 :

세계의 웨어러블 주사기 시장은 빈번한 투약이 필요한 당뇨병 및 자가면역 질환과 같은 만성 질환의 유병률 증가와 같은 몇 가지 중요한 요인들에 의해 견인되고 있습니다. 환자 친화적이고 비침습적인 약물 전달 솔루션에 대한 수요 증가 및 웨어러블 기술의 발전이 시장 성장을 지원합니다. 센서와 연결 기능을 통합한 스마트 웨어러블 주사기와 같은 기술 혁신은 약물 전달의 정확성과 환자 모니터링을 더욱 강화합니다. 게다가 재택 건강 관리 솔루션에 대한 동향 증가와 환자 중심의 케어 모델의 채택이 시장 확대에 기여하고 있습니다.

시장 성장 억제요인 :

유망한 성장 전망에도 불구하고 웨어러블 주사기 시장은 고가의 장비 비용, 규제 장애물, 기술적 복잡성과 관련된 과제에 직면하고 있습니다. 고급 웨어러블 주사기에는 고액의 초기 투자가 필요하므로 특히 의료 예산에 제약이 있는 개발 도상 지역에서는 보급이 제한될 수 있습니다. 또한 규제 당국의 승인과 엄격한 의료기기 표준 준수는 시장 진입과 제품 개척의 장벽이 될 수 있습니다. 또한 장비 오작동이나 정기적인 유지 보수 필요와 같은 기술적 문제는 사용자 만족도와 시장 침투에 영향을 줄 수 있습니다.

시장 기회 :

웨어러블 주사기 시장은 기술 혁신, 인구 동향, 건강 관리 제공 모델의 진화에 의해 큰 성장 기회를 가져옵니다. 디지털 헬스 플랫폼, 원격 모니터링, 인공지능(AI)과 같은 고급 기술의 통합은 웨어러블 주사기의 기능과 매력을 향상시킵니다. 개인화된 의료 및 표적 약물 전달 시스템의 용도 확대는 시장 성장의 새로운 길을 열어줍니다. 전략적 파트너십, 연구개발 투자, 비용 효율적이고 사용하기 쉬운 웨어러블 주사기의 개척은 새로운 기회를 활용하고 시장 주도권을 유지하는 데 필수적입니다.

이 보고서에서 다루는 주요 질문

세계의 웨어러블 주사기 시장 성장을 가속하는 주요 요인은 무엇인가?
다양한 건강 관리 환경에서 가장 널리 사용되는 웨어러블 주사기의 유형 및 용도는?
기술의 진보는 웨어러블 주사기 시장 경쟁 구도를 어떻게 바꾸고 있는가?
웨어러블 주사기 시장에 기여하는 주요 기업은 어디에서 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 웨어러블 주사기 시장의 새로운 동향 및 장래성은?

서문 : 주요 조사 결과
과거 시장 규모(백만 달러) 분석 : 최종 사용자별(2019-2023년)
현재 및 장래 시장 규모(백만 달러)의 분석 및 예측 : 최종 사용자별(2024-2033년)
- 병원 약국
- 소매 약국
- 전자상거래
시장의 매력 분석 : 최종 사용자별

제10장 세계의 웨어러블 주사기 시장 분석 : 지역별

서문
과거 시장 규모(백만 달러)의 분석 : 지역별(2019-2023년)
현재 및 장래 시장 매출(백만 달러)의 분석 및 예측(2024-2033년)
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카(MEA)
시장의 매력 분석 : 지역별

제11장 북미의 웨어러블 주사기 시장 분석

제12장 라틴아메리카의 웨어러블 주사기 시장 분석

제13장 유럽의 웨어러블 주사기 시장 분석

제14장 동아시아의 웨어러블 주사기 시장 분석

제15장 남아시아의 웨어러블 주사기 시장 분석

제16장 오세아니아의 웨어러블 주사기 시장

제17장 중동 및 아프리카(MEA)의 웨어러블 주사기 시장 분석

제18장 시장 구조 분석

시장 분석 : 기업 Tier별
주요 기업의 시장 점유율 분석
시장 현재 분석

제19장 경쟁 분석

경쟁 대시보드
경쟁의 상세 정보
- Medtronic PLC
- Enable Injections LLC
- Becton, Dickinson and Company
- Insulet Corporation
- Valeritas,Inc
- Dexcom, Inc.
- Ypsomed Group
- West Pharmaceutical Services, Inc.
- Bespak
- Amgen Inc.

제20장 사용된 전제조건 및 약어

제21장 조사 방법

AJY

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for wearable injectors. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Wearable Injectors Market Size (2024E): USD 7.7 Million
Projected Market Value (2033F): USD 17.8 Million
Global Market Growth Rate (CAGR 2024 to 2033): 9.8%

Wearable Injectors Market - Report Scope:

Wearable injectors are advanced medical devices designed to deliver medications subcutaneously over extended periods. These devices cater to chronic disease management, including diabetes and rheumatoid arthritis, and are preferred for their convenience and ease of use. The wearable injectors market serves a range of healthcare settings, including hospitals, clinics, and homecare environments, with innovations such as patch pumps and automated drug delivery systems enhancing patient compliance and treatment efficacy.

Market Growth Drivers:

The global wearable injectors market is driven by several key factors, including the rising prevalence of chronic diseases such as diabetes and autoimmune disorders, which necessitate frequent medication. The increasing demand for patient-friendly and non-invasive drug delivery solutions, coupled with advancements in wearable technology, supports market growth. Innovations such as smart wearable injectors with integrated sensors and connectivity features further enhance drug delivery precision and patient monitoring. Additionally, the growing trend towards home-based healthcare solutions and the adoption of patient-centric care models contribute to the market expansion.

Market Restraints:

Despite promising growth prospects, the wearable injectors market faces challenges related to high device costs, regulatory hurdles, and technical complexities. The high initial investment required for advanced wearable injectors may limit their adoption, particularly in developing regions with constrained healthcare budgets. Regulatory approval processes and compliance with stringent medical device standards can also pose barriers to market entry and product development. Furthermore, technical issues such as device malfunction and the need for regular maintenance can impact user satisfaction and market penetration.

Market Opportunities:

The wearable injectors market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of advanced technologies such as digital health platforms, remote monitoring, and artificial intelligence (AI) enhances the functionality and appeal of wearable injectors. Expanding applications in personalized medicine and targeted drug delivery systems open new avenues for market growth. Strategic partnerships, investment in R&D, and the development of cost-effective and user-friendly wearable injectors are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the wearable injectors market globally?
Which wearable injector types and applications are most popular in different healthcare settings?
How are technological advancements reshaping the competitive landscape of the wearable injectors market?
Who are the key players contributing to the wearable injectors market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global wearable injectors market?

Competitive Intelligence and Business Strategy:

Leading players in the global wearable injectors market, including Insulet Corporation, Medtronic PLC, and Tandem Diabetes Care, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced wearable injectors with features such as automated insulin delivery, real-time data monitoring, and connectivity to digital health platforms. Collaborations with healthcare providers, technology firms, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on patient education, clinical trials, and evidence-based practices fosters market growth and enhances patient outcomes in the rapidly evolving wearable injectors landscape.

Key Companies Profiled:

Insulet Corporation
Medtronic PLC
Tandem Diabetes Care
Becton, Dickinson and Company
Novo Nordisk A/S
Eli Lilly and Company
Roche Holding AG
Ypsomed Holding AG
Abbott Laboratories
Senseonics Holdings, Inc.

Key Segments Covered in Global Wearable Injectors Market Research

Product:

Body-worn patch injector
Off-body worn injectors

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
E-commerce

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Recent Product launches/ Approvals
4.4. PESTEL Analysis
4.5. Key Promotional Strategies, By Key Players
4.6. Porter's Analysis
4.7. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Injectors Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increase in R&D Spending
- 5.2.2. Growing Lifestyle Disease Prevalence
- 5.2.3. Cost of Products
- 5.2.4. Product Features
- 5.2.5. Advancements in Technology
- 5.2.6. Changes in Regulatory Policies
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By End User
- 6.1.3. By Country
6.2. 2022 Market Scenario

7. Global Wearable Injectors Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
- 8.3.1. Body-worn patch injector
- 8.3.2. Off-body worn injectors
8.4. Market Attractiveness Analysis By Product

9. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. E-commerce
9.4. Market Attractiveness Analysis By End User

10. Global Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033, By Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Product
- 11.3.3. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Product
- 11.4.3. By End User
11.5. Market Trends
11.6. Drivers and Restraints - Impact Analysis
11.7. Key Players - Intensity Mapping
11.8. Country Level Analysis & Forecast
- 11.8.1. U.S. Wearable Injectors Market Analysis
  - 11.8.1.1. Introduction
  - 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.1.2.1. By Product
    - 11.8.1.2.2. By End User
- 11.8.2. Canada Wearable Injectors Market Analysis
  - 11.8.2.1. Introduction
  - 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.8.2.2.1. By Product
    - 11.8.2.2.2. By End User

12. Latin America Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Mexico
  - 12.3.1.2. Brazil
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Product
- 12.3.3. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By End User
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Key Players - Intensity Mapping
12.8. Country Level Analysis & Forecast
- 12.8.1. Mexico Wearable Injectors Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Product
    - 12.8.1.2.2. By End User
- 12.8.2. Brazil Wearable Injectors Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Product
    - 12.8.2.2.2. By End User
- 12.8.3. Argentina Wearable Injectors Market Analysis
  - 12.8.3.1. Introduction
  - 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.3.2.1. By Product
    - 12.8.3.2.2. By End User

13. Europe Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. BENELUX
  - 13.3.1.7. Russia
  - 13.3.1.8. Rest of Europe
- 13.3.2. By Product
- 13.3.3. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Wearable Injectors Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Product
    - 13.8.1.2.2. By End User
- 13.8.2. Italy Wearable Injectors Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Product
    - 13.8.2.2.2. By End User
- 13.8.3. France Wearable Injectors Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Product
    - 13.8.3.2.2. By End User
- 13.8.4. U.K. Wearable Injectors Market Analysis
  - 13.8.4.1. Introduction
  - 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.4.2.1. By Product
    - 13.8.4.2.2. By End User
- 13.8.5. Spain Wearable Injectors Market Analysis
  - 13.8.5.1. Introduction
  - 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.5.2.1. By Product
    - 13.8.5.2.2. By End User
- 13.8.6. BENELUX Wearable Injectors Market Analysis
  - 13.8.6.1. Introduction
  - 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.6.2.1. By Product
    - 13.8.6.2.2. By End User
- 13.8.7. Russia Wearable Injectors Market Analysis
  - 13.8.7.1. Introduction
  - 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.7.2.1. By Product
    - 13.8.7.2.2. By End User

14. East Asia Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. China
  - 14.3.1.2. Japan
  - 14.3.1.3. South Korea
- 14.3.2. By Product
- 14.3.3. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. China Wearable Injectors Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By End User
- 14.8.2. Japan Wearable Injectors Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By End User
- 14.8.3. South Korea Wearable Injectors Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Product
    - 14.8.3.2.2. By End User

15. South Asia Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Malaysia
  - 15.3.1.4. Thailand
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Product
- 15.3.3. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. India Wearable Injectors Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By End User
- 15.8.2. Indonesia Wearable Injectors Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By End User
- 15.8.3. Malaysia Wearable Injectors Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By End User
- 15.8.4. Thailand Wearable Injectors Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Product
    - 15.8.4.2.2. By End User

16. Oceania Wearable Injectors Market 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Product
- 16.3.3. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Wearable Injectors Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By End User
- 16.8.2. New Zealand Wearable Injectors Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Wearable Injectors Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkey
  - 17.3.1.3. North Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Product
- 17.3.3. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Wearable Injectors Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By End User
- 17.8.2. Turkey Wearable Injectors Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By End User
- 17.8.3. South Africa Wearable Injectors Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Product
    - 17.8.3.2.2. By End User
- 17.8.4. North Africa Wearable Injectors Market Analysis
  - 17.8.4.1. Introduction
  - 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.4.2.1. By Product
    - 17.8.4.2.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Competition Deep Dive
- 19.2.1. Medtronic PLC
  - 19.2.1.1. Overview
  - 19.2.1.2. Product Portfolio
  - 19.2.1.3. Sales Footprint
  - 19.2.1.4. Key Financials
  - 19.2.1.5. SWOT Analysis
  - 19.2.1.6. Strategy Overview
    - 19.2.1.6.1. Marketing Strategy
    - 19.2.1.6.2. Product Strategy
    - 19.2.1.6.3. Channel Strategy
- 19.2.2. Enable Injections LLC
  - 19.2.2.1. Overview
  - 19.2.2.2. Product Portfolio
  - 19.2.2.3. Sales Footprint
  - 19.2.2.4. Key Financials
  - 19.2.2.5. SWOT Analysis
  - 19.2.2.6. Strategy Overview
    - 19.2.2.6.1. Marketing Strategy
    - 19.2.2.6.2. Product Strategy
    - 19.2.2.6.3. Channel Strategy
- 19.2.3. Becton, Dickinson and Company
  - 19.2.3.1. Overview
  - 19.2.3.2. Product Portfolio
  - 19.2.3.3. Sales Footprint
  - 19.2.3.4. Key Financials
  - 19.2.3.5. SWOT Analysis
  - 19.2.3.6. Strategy Overview
    - 19.2.3.6.1. Marketing Strategy
    - 19.2.3.6.2. Product Strategy
    - 19.2.3.6.3. Channel Strategy
- 19.2.4. Insulet Corporation
  - 19.2.4.1. Overview
  - 19.2.4.2. Product Portfolio
  - 19.2.4.3. Sales Footprint
  - 19.2.4.4. Key Financials
  - 19.2.4.5. SWOT Analysis
  - 19.2.4.6. Strategy Overview
    - 19.2.4.6.1. Marketing Strategy
    - 19.2.4.6.2. Product Strategy
    - 19.2.4.6.3. Channel Strategy
- 19.2.5. Valeritas,Inc
  - 19.2.5.1. Overview
  - 19.2.5.2. Product Portfolio
  - 19.2.5.3. Sales Footprint
  - 19.2.5.4. Key Financials
  - 19.2.5.5. SWOT Analysis
  - 19.2.5.6. Strategy Overview
    - 19.2.5.6.1. Marketing Strategy
    - 19.2.5.6.2. Product Strategy
    - 19.2.5.6.3. Channel Strategy
- 19.2.6. Dexcom, Inc.
  - 19.2.6.1. Overview
  - 19.2.6.2. Product Portfolio
  - 19.2.6.3. Sales Footprint
  - 19.2.6.4. Key Financials
  - 19.2.6.5. SWOT Analysis
  - 19.2.6.6. Strategy Overview
    - 19.2.6.6.1. Marketing Strategy
    - 19.2.6.6.2. Product Strategy
    - 19.2.6.6.3. Channel Strategy
- 19.2.7. Ypsomed Group
  - 19.2.7.1. Overview
  - 19.2.7.2. Product Portfolio
  - 19.2.7.3. Sales Footprint
  - 19.2.7.4. Key Financials
  - 19.2.7.5. SWOT Analysis
  - 19.2.7.6. Strategy Overview
    - 19.2.7.6.1. Marketing Strategy
    - 19.2.7.6.2. Product Strategy
    - 19.2.7.6.3. Channel Strategy
- 19.2.8. West Pharmaceutical Services, Inc.
  - 19.2.8.1. Overview
  - 19.2.8.2. Product Portfolio
  - 19.2.8.3. Sales Footprint
  - 19.2.8.4. Key Financials
  - 19.2.8.5. SWOT Analysis
  - 19.2.8.6. Strategy Overview
    - 19.2.8.6.1. Marketing Strategy
    - 19.2.8.6.2. Product Strategy
    - 19.2.8.6.3. Channel Strategy
- 19.2.9. Bespak
  - 19.2.9.1. Overview
  - 19.2.9.2. Product Portfolio
  - 19.2.9.3. Sales Footprint
  - 19.2.9.4. Key Financials
  - 19.2.9.5. SWOT Analysis
  - 19.2.9.6. Strategy Overview
    - 19.2.9.6.1. Marketing Strategy
    - 19.2.9.6.2. Product Strategy
    - 19.2.9.6.3. Channel Strategy
- 19.2.10. Amgen Inc.
  - 19.2.10.1. Overview
  - 19.2.10.2. Product Portfolio
  - 19.2.10.3. Sales Footprint
  - 19.2.10.4. Key Financials
  - 19.2.10.5. SWOT Analysis
  - 19.2.10.6. Strategy Overview
    - 19.2.10.6.1. Marketing Strategy
    - 19.2.10.6.2. Product Strategy
    - 19.2.10.6.3. Channel Strategy